Ultrastructure of Exogenous Surfactants Using Cryogenic Scanning Electron Microscopy

Abstract

Therapy with specialised biomaterials, exogenous surfactants, is known to significantly decrease the mortality rates in Respiratory Distress Syndrome (RDS). Surfactants available commercially vary widely in composition and biophysical properties. The present paper studies the ultrastructure of three exogenous surfactants used for the treatment of Respiratory Distress Syndrome, namely, Survanta™, ALEC™ and Exosurf Neonatal™ with respect to their ability to form liposomes using cryogenic scanning electron microscopy. Liposomal organisation is more obvious in Exosurf than in Survanta and is most pronounced in ALEC. ALEC forms closed regular liposomes with an onion-ring-like internal bilayer arrangement. Survanta forms open membranous structures with wavy ribbon-like membranes. The complex membrane-like structures seen with Survanta may be due to the interaction of lipids with surfactant-specific proteins present in this surfactant which is derived from natural lung extracts and might indicate superior spreading at the lipid-water interface. Artificial protein-free surfactants (ALEC and Exosurf) did not appear to form these open membranous structures. Further study of the ultrastructure of possible biomaterials as surfactants could help in the development of new, improved artificial protein-free surfactants with open membranous structures that might facilitate spreading at the air-liquid interface of lungs.

Get full access to this article

View all access options for this article.

References

1. Avery, M. E. 1959. “Surface properties in relation to atelectasis and hyaline membrane disease”, Am. J. Dis. Child., 97: 517–523.

2. Ten Centre Study Group . 1987. “Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies”, B. M. J., 294: 991–996.

3. Chevalier, G. and A. J. Collet . 1972. “In vivo incorporation of choline-3H, leucine-3H and galactose-3H in alveolar type II pneumocytes in relation to surfactant synthesis. A quantitative autoradiographic study in mouse by electron microscopy”, Anat. Rec., 174: 289–310.

4. Morton, N. S. 1990. “Pulmonary surfactant: physiology, pharmacology and clinical uses”, J. Appl. Med., 5: 347–356.

5. Clements, J. A. 1982. “Lung surfactant compositions”, United States Patent #4, 312, 860.

6. Bangham, A. D. , N. G. A. Miller , R. J. Davies , L. A. Greendig and C. J. Morley . 1984. “Introductory remarks about artificial lung expanding compounds (ALEC)”, Colloids Surfaces, 10: 337–341.

7. Bhadriraju, K. and J. Bellare . 1993. “A cryo-SEM technique developed and applied to surfactant liposomes”, Proc. 51st Annual Meeting of Microscopy Society of America.

8. Zasadzinnski, J. A. N. , L. E. Scriven and H. T. Davis . 1985. “Liposome structure and defects”, Philosophical Magazine A, 51: 287–302.

9. Corcoran, J. D. , P. Berggren , B. Sun , H. L. Halliday , B. Robertson and T. Curstedt . 1994. “Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits”, Arch. Dis. Child., 71: F165–F169.

10.

10. Vermont—Oxford Neonatal Network . 1996. “A multi center randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome”, Pediatrics, 97: 1–6.

11.

11. Sasaki, M. 1990. “Comparison of five pulmonary surfactants: In vitro surface properties and ultrastructures”, J. Iwate Med. Ass., 42: 883–896.

12.

12. Kitamura, A. , T. Kiyota , M. Tomohiro , A. Umeda , S. Lee , T. Inoue and G. Sugihara . 1999. “Morphological behavior of acidic and neutral liposomes induced by basic amphiphilic alpha-helical peptides with systematically varied hydrophobic-hydrophilic balance”, Biophys J., 76: 1457–1468.